TrialThe Lancet. Global health2025

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial.

Angelique Kany Kany Luabeya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.